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Abstract
Background: The Kenyan highlands were malaria-free before the 1910s, but a series of malaria epidemics have
occurred in the highlands of western Kenya since the 1980s. Longitudinal studies of the genetic structure,
complexity, infection dynamics, and duration of naturally acquired Plasmodium falciparum infections are needed to
facilitate a comprehensive understanding of malaria epidemiology in the complex Kenyan highland eco-
epidemiological systems where malaria recently expanded, as well as the evaluation of control measures.
Methods: We followed a cohort of 246 children residing in 3 villages at altitudes 1430 - 1580 m in western Kenya.
Monthly parasitological surveys were undertaken for one year, yielding 866 P. falciparum isolates that were
analyzed using 10 microsatellite markers.
Results: Infection complexity and genetic diversity were high (HE = 0.787-0.816), with ≥83% of infections harboring
more than one parasite clone. Diversity remained high even during the low malaria transmission season. There was
no significant difference between levels of genetic diversity and population structure between high and low
transmission seasons. Infection turn-over rate was high, with the average infection duration of single parasite
genotypes being 1.11 months, and the longest genotype persistence was 3 months.
Conclusions: These data demonstrate that despite the relatively recent spread of malaria to the highlands, parasite
populations seem to have stabilized with no evidence of bottlenecks between seasons, while the ability of
residents to clear or control infections indicates presence of effective anti-plasmodial immune mechanisms.
Background
Plasmodium falciparum malaria is presently among the
most fatal diseases in the East African highlands, where
an estimated 34 million people remain at risk [1]. Unlike
the endemic lowlands, these relatively cool high-eleva-
tion areas were basically malaria-free before the 1910s.
Sporadic malaria epidemics occurred from the 1920s to
the 1950s, but a series of highly fatal epidemics have
occurred in the highlands of western Kenya since the
1980s, the most recent occurring during 2004 [2].
Unlike the lowlands where malaria has been endemic
for generations, populations in highland areas that are
less exposed to malaria parasites are expected to be less
immune and hence more vulnerable to epidemics. It is
probable, however, that successive waves of infection
may have generated some level of immunity among the
highland residents. Immunity to malaria comes gradu-
ally, consequent to repeated or persistent infection for
years, during which period an individual develops
immune responses to most parasite variants circulating
in a particular area. The fact that the diversity of malaria
parasites is a sequel of both clonal antigenic variation
and allelic polymorphism means that the period of
infection persistence is an important parameter [3].
Moreover, acquisition of anti-plasmodial immunity can
affect infection dynamics by shortening infection persis-
tence [4].
In a previous study, we detected plasmodial infections
in one highland area of Kenya with some individuals
being more frequently parasitemic than others, but we
did not know whether this was due to infection persis-
tence by one or more strains or due to re-infections [5].
Obviously, estimates of parasite burden based solely on
parasite detection provide only a rudimentary measure,
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such as infection persistence or the rate of relapse of
latent infections, the incidence of new infections, and
the rate of infection clearance from the circulation [6].
As such, single-time-point sampling as occurs in
cross-sectional studies may not give a comprehensive
epidemiological picture [7]. A longitudinal tracking of
parasites within individuals would therefore provide bet-
ter insight into the role of such factors in infection
d y n a m i c s ,w h i l ea tt h es a m et i m ep r o v i d i n gas u r r o g a t e
measure of population immunity [3,4]. Studies of the
duration of plasmodial infections in natural populations
are lacking in the East African highlands. Moreover,
without parasite typing data, it is impossible to reliably
estimate the duration of infections among residents of
areas with ongoing transmission [8]. The use of multiple
genetic markers helps prevent the overestimation of clo-
nal duration by minimizing the chance of misclassifying
new infections as persistent, as the probability of differ-
ent plasmodial strains having identical genotypes at
multiple markers is reduced [9].
Malaria parasite populations in endemic Africa are
highly diverse, varying both genetically and phenotypi-
cally (virulence, drug resistance, and transmissibility)
[10]. Available data show that there is a direct correla-
tion between the number of genotypes per person and
transmission intensity [11,12]. Many recent cross-
sectional studies have drawn attention to the relation-
ship between the multiplicity of infection (MOI), trans-
mission intensity, and genetic structure. While these
studies have established that MOI is negatively asso-
ciated with disease severity, they also provide another
reliable surrogate measure of transmission intensity and
population immunity [7,13,14]. However, like infection
duration studies, longitudinal studies of infection com-
plexity and dynamics are lacking in the East African
highlands.
In this paper, we report a longitudinal study on
malaria parasite population genetic diversity and infec-
tion dynamics in the western Kenya highlands based on
a cohort of school children. We utilize highly poly-
morphic microsatellite markers to compare infection
complexity, genetic diversity, and population structure
between transmission seasons to determine if a reduc-
tion in transmission has an effect on parasite population
structure in the highlands. Understanding malaria para-
site population genetic structure and infection dynamics
may be useful in the assessment of malaria control stra-
tegies [15]. In addition, we determine how long indivi-
dual malaria parasite genotypes persist in humans.
Infections that last longer have higher transmission
potential [16] and also indicate relatively low levels of
immunity, while quickly cleared infections indicate high
levels of population immunity [4,13].
Methods
Study area and population
This study took advantage of the availability of samples
from our previous study [5]. The study was carried out
in 3 villages: Iguhu, Makhoko and Sigalagala at altitude
1430-1580 m in Kakamega district, Western Kenya. The
area has two rainy seasons, averaging 1800 mm rainfall
annually. The long rainy season occurs between mid-
March to May, while September-October is the short
rainy season. Malaria prevalence peaks in this area
usually lag 1-2 months after the rains [17]. Over the
past few decades, the area has undergone significant
land-use changes with massive deforestation, inducing
micro-climatic changes that enhance survivorship and
reproduction of Anopheles gambiae mosquitoes, the
main malaria vector species in this area [18]. Daily tem-
peratures range between 13.8 - 28°C. The entomological
inoculation rate (EIR) at Iguhu was 16.6 during 2003-
2004 [19], while it was 0.05 and 0.04 at Makhokho and
Sigalagala respectively during 1999-2000 [20]. Other
d e t a i l so ft h es t u d ya r e ah a v eb e e np r e v i o u s l yr e p o r t e d
[21]. The DNA analyzed in this study was obtained
from a cohort of 246 randomly selected apparently
healthy primary school children (84 from Iguhu, 81
from Makhokho and 81 from Sigalagala). A question-
naire was used to capture demographic data and treat-
ment history. The children (5-17 years) were followed
from January to December 2006 with monthly parasito-
logical surveys, after obtaining their assent and informed
consent from parents or guardians. Blood smear results
were immediately reported to the study participants and
their parents or guardians. However, since the Kenya
Ministry of Health guidelines did not advise treatment
of asymptomatic persons, parasitemic individuals were
advised to seek anti-malarial treatment at the nearby
Iguhu Health Center if they subsequently developed
fever or any other signs of malaria, such as chills, head-
ache, muscle pain, nausea, or vomiting. The study was
approved by Kenya Medical Research Institute Ethical
Review Committee and the Institutional Review Board
of the University of California, Irvine.
Microsatellite genotyping
Parasite DNA was extracted from the study subjects’
blood samples preserved on Whatman 3 MM filter
papers, using saponin/chelex-100, and infections were
diagnosed by nested PCR amplification of the species-
specific small-subunit ribosomal RNA gene, as pre-
viously reported [22]. The PCR products were run in
ethidium bromide-stained 2% agarose gels, and visua-
lized under ultraviolet light. Negative PCR samples were
re-amplified, and infections were declared negative only
after repeated DNA extraction and re-amplification for
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mic DNA from 866 P. falciparum PCR-positive samples
was then genotyped using 10 microsatellite markers
(TA1, TA42, TA81, TA87, TA109, ARA2, 2490, Polya,
Pfpk2, Pfg377) [23], on LI-Cor 4300 automated genetic
analyzer, using previously reported protocols [24].
Since blood-stage malaria parasites are haplotypic, the
presence of more than one allele at any one locus was
considered diagnostic of a mixed infection. Only minor
alleles with peaks ≥33% the height of the predominant
allele were considered in case of mixed-clone infections
[25]. Where mixed infections occurred, the predominant
allele was used in estimates of allele frequencies and
population structure [15,25].
Analysis of genetic diversity and population structure
We examined the difference in genetic diversity between
low and high malaria transmission seasons. To avoid
compounding effects of repeated sampling, the low
transmission season was represented by samples col-
lected in April, while the high transmission season was
represented by the June samples; based on a considera-
tion of both the usual malaria transmission patterns in
the area [17], and our monthly malaria prevalence data.
Genetic diversity of P. falciparum infections was mea-
sured by the number of observed (Na) and effective (ne)
alleles per locus, Nei’s unbiased genetic diversity (HE),
Nei genetic distance (D), and Shannon’s index (I), using
GenAlEX6.1 software [26]. A paired t-test was used to
compare differences in mean HE values obtained at each
locus during the low and high transmission seasons.
Because no genetic differentiation was observed among
the three villages (D = 0; respective HE values for Iguhu,
Makhokho and Sigalagala were: 0.82, 0.77 and 0.79 for
the low and 0.80, 0.79 and 0.81 for the high transmis-
sion season), samples from the three sites were pooled
and analyzed as the same population. Proportions of
mixed-genotype infections between seasons were com-
pared using Fisher’s exact test. Hierarchical analysis of
molecular variance (AMOVA) was performed to deter-
mine the genetic variation between the low and high
transmission seasons using ARLEQUIN [27].
Factors such as close physical linkage among loci,
inbreeding/selfing, genetic drift, or the Wahlund effect
may cause linkage disequilibrium (LD) [28]. Estimates of
LD can thus give important clues about population
structure and history. Pair-wise LD between markers
was examined for the low and high transmission sea-
sons, using GENEPOP3.4 [29].
Effective population size and genetic bottleneck analysis
The effective population sizes (Ne) in the low and high
transmission seasons were calculated from the observed
heterozygosity, assuming a microsatellite mutation rate
of 1.59 × 10
-4 for P. falciparum, as previously described
[25]. Evidence for severe reduction in Ne (genetic bot-
tleneck) between the two seasons was further examined
by the Wilcoxon Signed-Rank test, under three models:
the infinite alleles model (IAM), stepwise mutation
model (SMM) and two-phase model (TPM), using BOT-
TLENECK1.2.02 [30]. Evidence for allele frequency dis-
tortion which occurs at neutral loci during bottlenecks
was also assessed using the “mode-shift” indicator [31].
Differentiating between new and pre-existing infections
and estimates of infection duration
To differentiate between new and pre-existing infections
and to estimate durations of infecting parasite geno-
types, we followed, with modification, the method of
Franks and colleagues [3], which utilized the analysis of
alleles at multiple loci. Briefly, we first identified and
ranked the most polymorphic loci by obtaining hetero-
zygosity data for the 10 microsatellites across all sam-
ples. The most polymorphic loci, with HE ≥ 0.8 (Polya,
TA109, TA87, TA1, Pfpk2, TA81 and ARA2 in descend-
ing order) were chosen for this analysis. The January
samples were used as the reference baseline genotype. If
the parasite sample in the subsequent month showed
distinct alleles in the most polymorphic locus (Polya),
we examined the next most polymorphic locus (TA109)
to determine whether new alleles were present at this
locus as well, until all 7 loci were examined with refer-
ence to the baseline. The prevalence of new infections
was estimated sequentially on a month-by-month basis.
Thus, if a new allele absent in a previous month was
observed, a new infection was counted. On the other
hand, if each of the loci showed at least one identical
allele to the baseline sample, the initial infection was
considered persistent. However, PCR may fail to amplify
a clone when parasitemia is low [32] or when parasites
are sequestrated [7,9]. To account for this possibility, we
accommodated one missing data point between conse-
cutive months, such that if, for example, the initial allele
was present in the second month but not detected again
until the fourth month, we still considered it a persistent
infection. The duration of a parasite genotype was then
calculated as the summation of the number of consecu-
tive months from the initial infection to last month of
persistence.
The use of single polymorphic markers in determining
malaria parasite genotype persistence has also been
reported [33]. Because the ten microsatellite markers
vary in polymorphism, the available dataset offered us
an opportunity to evaluate the effects of marker poly-
morphism on the estimated infection durations. We
determined genotype durations using each of the 10
microsatellite markers, and then employed the Kaplan-
Meier survival estimator to compare the overall
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among locus pairs were then compared using the
Tukey-Kramer HSD test (JMP 5.1, SAS Institute).
Estimates of incidence rates
Incidence rates were estimated based on new infections
among individuals who were P. falciparum-negative at
the beginning of the study (n = 139); i.e. considering
only the first infection detected in each of these indivi-
duals during the year. We also determined the propor-
tion of infected individuals (n = 157) that acquired
additional infections during the 12-months study period.
Results
246 subjects were enrolled in the study, but 19 were lost
to follow-up over the first 11 months, with an additional
170 subjects lost to follow-up during final month of the
study, due to the Christmas recess. 53 of the 246 sub-
jects in the cohort reported developing clinical malaria,
with antimalarial treatment on a total of 77 occasions.
63.6% (49/77) of the cases were self-medicated, and the
remaining (36.4%) were treated by clinicians. 92.2% (71/
77) of the cases were treated with sulfadoxine-pyri-
methamine, and 3.9% (3/77) with amodiaquine or qui-
nine. Nearly half (43.4%) of 53 subjects who reportedly
had clinical signs of malaria and received treatment at
some point during the study were parasite-negative at
the times of our sampling, throughout the year. Overall,
30 of these 53 subjects contributed 41 parasite-positive
blood samples during the study period; 23 of these sam-
ples were obtained at least two months before or after
treatment, while 18 were obtained within one month
post-treatment, of which 16 of these 18 were new infec-
tions. Overall, a total of 866 samples were genotyped
during the 12-months study period.
Microsatellite diversity and analysis of molecular
variance (AMOVA)
The microsatellite markers were highly polymorphic,
with monthly mean number of alleles per locus being
12.2, ranging from 8 (Pfg377) to 27 (Polya). Genetic
diversity was high throughout the year (HE range: 0.787 -
0.816), with monthly number of alleles (Na) substantially
higher than the number of effective alleles (ne)[ r a n g e=
3 - 27 vs 1.5 - 17.6, respectively; mean Na - ne =5 . 7 ,9 5 %
CI = 5.2 - 6.1; t = 23.2 df = 119, P < 0.001]. Variability
data for the low versus high malaria transmission seasons
were respectively as follows: Na = 12.4 vs 13.2; ne =6 . 7 5
vs 6.52; He = 0.789 vs 0.793, and I = 2.0 for both seasons
(Figure 1). Parasite population unbiased genetic diversi-
ties for the low versus high transmission seasons were
both high and exhibited no statistical difference
(HE = 0.803 vs 0.803; 95% CI = -0.016 - 0.016, t = 0, df =
9, P = 1.0). AMOVA revealed no significant difference in
genetic structure between the low and high transmission
seasons (Table 1).
Figure 1 Microsatellite allelic patterns across transmission seasons. No significant difference in diversity was observed between the low
and high malaria transmission seasons. Whiskers represent standard error values.
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Only three and one out of 45 possible pair-wise tests
showed significant LD (P <0 . 0 5 )i nt h el o wa n dh i g h
transmission seasons, respectively, with no significant
association involving loci on the same chromosome.
Moreover, no locus pair remained in LD after applying
both the highly conservative Bonferroni correction and the
less conservative Benjamini-Yekutieli false discovery rate
(B-Y FDR) procedure for multiple comparisons [34,35].
Effective population size and bottleneck analysis
B a s e do nt h ef o r m u l a ea n da s s u m p t i o n sr e p o r t e db y
Anderson and colleagues [25], effective population size
(Ne) was high during both seasons; Ne with 95% confi-
dence intervals were: 9037 (3883, 20585) and 8727
(3750, 19880) under IAM, and 46193 (19850, 105224)
and 39808 (17107, 90679) under SMM for the low and
high transmission seasons, respectively. Bottleneck ana-
lyses using the Wilcoxon Signed-Rank test under all
known microsatellite mutation models gave no signifi-
cant result, except for a marginally significant bottleneck
under IAM for the low transmission season (Table 2).
Overall, alleles showed a normal, L-shaped distribution
across seasons, suggesting no significant seasonal decline
in effective population size in this highland area.
Monthly infection complexity and stability of the
minimum number of clones
Data for December were not used for monthly infection
complexity analysis because of a small number of
infected samples (n = 11; all multi-clonal). The preva-
lence of mixed-clone infections was high (83.3 - 98.5%),
while the prevalence of single infections was generally
low (< 17%; Figure 2). There was a significant difference
in infection prevalence during the low (28%) and high
(37%) transmission seasons (P = 0.039), but no differ-
ence was observed in infection complexity between the
two seasons (P = 0.641). The average number of P. falci-
parum clones per infection for the entire study period
was 2.5 (range 1- 6).
Incidence rates and infection persistence
The estimated plasmodial infection incidence rate was
669 per 1,000 person years. The reinfection or superin-
fection rate was high (86.6%). The multilocus estimation
showed the average duration of individual parasite geno-
types to be 1.11 months, with the majority (92.2%) of
infecting genotypes persisting for only one month
(range 1-3 months). Considering infections from indivi-
duals who fell sick and got malaria treatment at some
point during the year versus those who never got treat-
ment at all, the proportion of infections lasting more
than one month was higher among individuals who
received treatment than among those who were asymp-
tomatic throughout the test period and never got treated
(20% vs 4.7%, P = 0.01). There was a wide variation in
infection durations estimated by individual microsatellite
markers. The less polymorphic loci gave longer geno-
type persistence estimates. The highly polymorphic mar-
kers (e.g. Polya and TA109) yielded statistically similar
mean infection duration estimates to the multilocus esti-
mation (Table 3).
Discussion
The dynamic nature of plasmodial infections renders
longitudinal studies the most desirable for a comprehen-
sive understanding of malaria epidemiology [7], more so
in the complex highland eco-epidemiological systems
where malaria recently expanded [2]. In this study, we
employed a panel of 10 highly polymorphic microsatel-
lite markers to determine the seasonal population struc-
ture, infection duration, complexity and dynamics
throughout the year in one highland area of western
Kenya.
Samples from the three villages were analyzed
together, since the villages are near to each other
(within a 5 km radius) and there were no differences in
genetic diversity observed between the low and high
transmission seasons, contrary to what would be
expected based on the substantial differences in EIR
among the sites. A number of possible explanations may
account for this observation. First the EIR data cited
were obtained in different years; perhaps a clearer EIR
picture could have been obtained with data obtained
Table 1 Analysis of molecular variance (AMOVA) among
Plasmodium falciparum populations during the low and
high transmission seasons in a highland area of western
Kenya.
Source of
variation
df SS Variance
components
Percent
variation
P
value
Between
seasons
1 5.23 0.018 0.45 0.058
Within seasons 147 550.31 4.014 99.55
Total 148 555.55 4.032 100
Table 2 P values for the bottleneck analysis of
Plasmodium falciparum populations during the low and
high malaria transmission seasons in a highland area of
western Kenya.
Model
§
Season
IAM SMM TPM Mode-shift
Low transmission (n = 64) 0.04199* 0.99902 0.72168 Normal
High transmission (n = 85) 0.05273 1.00000 0.83887 Normal
§ The Wilcoxon test was used to test for heterozygosity excess under infinite
allele (IAM), stepwise mutation (SMM) and two-phase (TPM) models. P values
are indicated under each model type. Parameters for TPM were: variance =
30; proportion of SMM = 70%. Estimates were based on 1,000 replications.
n = number of samples tested.
* Indicates statistical significance at P <0 . 0 5 .
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EIR estimates may have not represented all the areas
where the children resided [20]. Third, human travel
may have facilitated parasite introduction and high gene
flow across the villages [2,24,36], also helped by both
the ready availability of the asymptomatic, untreated
malaria reservoir and the notably high efficiency of
malaria transmission by the vectors in the study area
[20]. In fact, earlier studies carried out in the study area
found no correlation between EIR and parasite preva-
lence or density [20], and similar conclusions were
derived from studies carried out in Tanzania [37].
The high infection incidence rate, high parasite popu-
lation genetic diversity, together with the high level of
among individual variability depicted by AMOVA sug-
gests that there is substantial heterogeneity in P. falci-
parum haplotype composition within this highland area.
Moreover, the absence of genotypic linkage disequili-
brium indicates that factors such as inbreeding/selfing,
genetic drift, or the Wahlund effect were not sufficiently
significant to cause changes in parasite genetic structure
[28]. The recent introduction of artemisinin-based com-
bination therapies (ACTs) has made a significant impact
on the clinical malaria burden in much of sub-Saharan
Africa, based on hospital data [38]. In Kenya, ACTs
were rolled out from July 2006 [39]. Three recent stu-
dies in Kenya show substantial reductions in the malaria
burden in some areas, but hospital data show that there
still exist many areas where malaria is not declining
[38]. Interim data from studies of malaria in western
Kenya before 2005 and 1-2 years after introduction of
ACTs also show a mixed pattern, with some high trans-
mission lowland areas showing a sharp decrease in
malaria prevalence during early 2007, followed by a
sharp increase in the late 2007-2008 [40]. We have also
noted a reduction of malaria prevalence in our study
sites in 2007-2008, and recovery of malaria prevalence
since 2009 (Y. Afrane, unpublished data). Consistent
Figure 2 Monthly prevalence of Plasmodium falciparum infections, indicating the proportions of single and mixed infections and
mean multiplicity of infection (MOI). Prevalence of mixed infections was high, with mean MOI consistently above 2.0 throughout the year.
Whiskers represent standard error values. December data were excluded because of insufficient sample size (n = 11; but all were mixed
infections).
Table 3 Comparison of infection duration estimates
among individual microsatellite markers and the
multilocus approach that involves 7 loci with HE > 8.0
Markers* Mean Duration
(Months)
Range
(Months)
HE
TA42 3.96 1-12 A 0.457
2490 2.87 1-12 B 0.737
Pfg377 2.74 1-12 B 0.660
ARA2 2.31 1-11 B C 0.857
TA81 2.23 1-11 B C 0.857
TA1 2.16 1-10 B C 0.892
TA87 1.87 1-11 C 0.901
PfPK2 1.85 1-10 C D 0.860
Polya 1.65 1-10 C D 0.940
TA109 1.64 1-10 C D 0.903
Multilocus - 7
markers (C)
1.11 1-3 D
*Markers not sharing the same letter in a column are significantly different
(P < 0.05) using the Tukey-Kramer honestly significant differences (HSD) test.
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tion structure between the lowland and highland sites
were observed over the years, suggesting that the cur-
rent malaria control efforts have not caused a major
change in parasite population structure [40]. African
mosquitoes are highly efficient malaria transmitters
[20,41], and while ACTs kill gametocytes, the infective
stage for mosquitoes, they may not have a quick impact
on malaria transmission ina r e a sw h e r eam i n o r i t yo f
infected individuals fall sick and seek treatment [38],
necessitating a consideration of treating the infected,
asymptomatic group if malaria is to be eliminated. Our
study focused on asymptomatic subjects, a significant
majority of whom received no antimalarial drug treat-
ment. Broadly, considering that only about 25% of plas-
modial inoculations in Africa result in clinical disease
[41], and because current treatment policies focus on
clinically sick people, with most estimates of malaria
burden based on hospital clinical data, the contribution
of parasites from the asymptomatic reservoir both to
genetic structure and estimates of malaria burden may
often be unnoticed.
More than 83% of the asymptomatic infections were
multi-clonal throughout the 12-months study period.
Similar estimates were obtain e df r o me a r l i e r cross-sec-
tional studies of symptomatic patients in the highlands
of Kakamega and Kisii, and the low lands of Kombebwa;
all in western Kenya [24]. Various epidemiological stu-
dies have established that there is a correlation between
the prevalence of multiple-genotype infections and
malaria transmission intensity [25,42]. While seasonal
fluctuations in MOI are common in low transmission
areas such as eastern Sudan (EIR <1) [16], we found no
d i f f e r e n c ei nM O Ib e t w e e nt h el o wa n dh i g ht r a n s m i s -
sion seasons. This is not surprising because firstly, our
s t u d ya r e ai st r a n s e c t e db yam a j o rr i v e ra tt h ev a l l e y
bottom, which provides a steady breeding ground for
malaria vectors throughout the year [5,43]. Secondly, a
significant majority of the infections were asymptomatic,
hence not treated, thereby having a greater opportunity
for recombination than if they were treated with effec-
tive drugs such as ACTs. Our results are consistent with
those from elsewhere, which show that in areas of rela-
tively high transmission, the number of clones in asymp-
tomatic infections tend to be consistent over long
periods of time, despite fluctuations in malaria transmis-
sion intensity [44].
Application of molecular genotyping to longitudinally-
collected parasite samples provides high utility in study-
ing infection dynamics, as it enable distinction between
pre-existing and newly acquired infections. Without
genotyping, we previously found detectable P. falci-
parum parasitemias among individuals in this area for
up to 12 months [5]. The present multi-locus typing
analysis, however, shows the longest single genotype
duration being only 3 months, sharply contrasting with
studies in Ghana where parasite genotypes persisted for
at least 10 months [3] and for over 12 months in Sudan
[16]. The significantly longer infection duration esti-
mates obtained with individual loci (up to 10-12
months) compared to multiple loci is consistent with
the view that multi-locus analysis helps prevent over-
estimation of infection duration [45]. Moreover, we
allowed for the dynamic nature of P. falciparum parasi-
temia [7,46] by accommodating one missing data point
in our duration estimates. The high prevalence of P. fal-
ciparum observed in our study area thus appears to be a
sequel of more frequent clearance and acquisition of
infections, rather than their protracted persistence.
It is difficult to determine the impact of antimalarial
drug treatment on infection clearance in our study.
First, the study was carried out in 2006, when resistance
to the most commonly used drug, sulfadoxine-pyri-
methamine, was supposed to be high. Majority of sam-
ples obtained within one month after treatment were
parasite-negative, with genotyping results showing only
2 out of 18 positive samples obtained within one month
of treatment being recrudescent; the rest were new
infections. Second, nearly half (43.4%) of the subjects
who reportedly had clinical signs of malaria and took
treatment at some point during the study period were
parasite-negative at the times of our sampling, through-
out the year; raising questions whether they were true
malaria cases that adequately responded to treatment
and never got re-infected. Because there are many
causes of fever and other malaria-like symptoms, cases
of presumptive treatment of fevers with antimalarial
drugs abound in Africa, with clinicians ignoring labora-
tory results in many cases [47]. Overall, however,
although the majority were parasite-negative one month
after treatment, the was a higher proportion of persis-
tent infections among the group of individuals who
reportedly developed clinical signs of malaria and got
treated than among those who were asymptomatic
throughout the study period. It is probable that a high
proportion of persistent infections among the group
that ultimately succumbed to clinical disease was caused
by relatively lower immunity levels and hence relatively
lower efficiency at clearing infections compared to the
untreated group [48]. Nevertheless, exclusion of all indi-
viduals that reportedly took antimalarial drugs at any
given time of the year did not change the overall esti-
mated duration of asymptomatic parasitemias in our
study area.
One limitation of our study was that fever was not
measured; hence we cannot rule out the possibility that
some of the parasitemias were associated with clinical
malaria. However, besides fever, clinical malaria is often
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headache, muscle weakness, joint pain and vomiting.
None of these symptoms were observed at the times of
sampling, and the majority of the children did not
report to have fallen sick afterwards or taken any anti-
malarial drug throughout the study period.
The rapid infection turnover observed in our study
area is typical of high transmission areas, and the
observed longest single genotype duration is within the
expected range (50 - 150 days) for areas of high trans-
mission [49,50]. These data indicate that a substantial
number of individuals tested in this area may have
developed sufficient immunity to deal with peripheral
parasitemia, hence the ability to clear infections faster
[4,7,51].
In a population having a constant effective size over the
recent past, there is an equal probability that loci show
excess or deficit of heterozygosity [30]. Overall, no het-
erozygosity excess was observed, implying there were no
bottlenecks in the P. falciparum population during the
low and high malaria transmission seasons in this high-
land area [25,30]. The high effective population sizes
observed in this area are important, because the bigger
the Ne, the better prepared will the population be to
resist genetic drift and to effectively adapt to adverse
environmental or other changes or pressures [52].
The observed high re-infection rates call for unrelent-
ing malaria control efforts, which should not ignore the
asymptomatic sub-population, if malaria is to be ulti-
mately eliminated in this area. The existence of parasite
populations that are largely sheltered within the asymp-
tomatic sub-population in this highland area, together
with a high prevalence of mixed infections pose a chal-
lenge to control efforts. First, asymptomatic parasitemias
are often so low that they often escape detection by
microscopy, the widely used tool for malaria diagnosis
[5]. Second, multi-clonal infections avail greater poten-
tial for enhanced parasite recombination and clonal
expansion, produce more gametocytes [16] and some
studies have found them to be more infectious to mos-
quitoes than single-clone infections [53,54]. These para-
sitemias may provide a substantial gametocyte reservoir
both for continual infection and as a precursor for the
next transmission season or epidemics when mosquitoes
become more abundant [2]. Moreover, recent anti-
malarial drug efficacy studies in 7 areas in Uganda with
widely varying malaria transmission intensities (EIRs 7 -
1564) have demonstrated that high MOIs are associated
with a greater risk of treatment failure [55]. Further-
more, malaria immunity is strain-specific, hence high
MOIs pose an obstacle to the development of effective
malaria vaccines [56]. Third, we observed a high effec-
tive population size (Ne) and a normal mode shift, with
lower ne than Na suggesting the presence of adaptive,
low-frequency alleles [25,52,57], meaning that P. falci-
parum populations in this area may be having a high
potential for responding to environmental changes and
pressures imposed by control measures.
Conclusions
Taken together, these data demonstrate that despite the
relatively recent spread of malaria to the highlands,
parasite populations seem to have attained a high effec-
tive population size, while the ability of the majority of
residents to clear or control infections indicates pre-
sence of effective anti-plasmodial immune mechanisms.
Asymptomatic parasitemias may be playing a large role
in maintaining the parasite burden in this area; they are
not presently targeted for treatment. Since the high
parasite population size, with high multi-clonality give a
biological advantage to the parasites for their survival
and spread [16,54], the use of efficacious drugs with
gametocyticidal activity, such as ACTs will go a long
way in curtailing the apparent parasites’ biological
advantages and prevent possible epidemics. A similar
strategy was successfully employed to block transmission
and prevent imminent epidemics on the Thai-Burmese
border [58], in Eritrea, Zanzibar, and KwaZulu-Natal in
South Africa [59]. However, given the above factors, it
will be necessary not only to deploy, but also to closely
and continuously monitor the progressive effectiveness
of all control interventions.
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